Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Oum Kelthoum Mamadou Djigo"'
Autor:
Oum Kelthoum Mamadou Djigo, Yacoub Ould Khalef, Mohamed Salem Ould Ahmedou Salem, Nicolas Gomez, Leonardo Basco, Sébastien Briolant, Ali Ould Mohamed Salem Boukhary
Publikováno v:
Infectious Diseases of Poverty, Vol 10, Iss 1, Pp 1-13 (2021)
Abstract Background The elimination of Plasmodium vivax malaria requires 8-aminoquinolines, which are contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to the risk of acute haemolytic anaemia. Several point-of-c
Externí odkaz:
https://doaj.org/article/2da700361d4743bfb6bc46bfc59615be
Autor:
Oum Kelthoum Mamadou Djigo, Mohamed Salem Ould Ahmedou Salem, Sileye Mamadou Diallo, Mohamed Abdallahi Bollahi, Boushab Mohamed Boushab, Aymeric Garre, Nasserdine Papa Mze, Leonardo Basco, Sébastien Briolant, Ali Ould Mohamed Salem Boukhary
Publikováno v:
Pathogens, Vol 10, Iss 8, p 931 (2021)
Plasmodium vivax malaria is endemic in Mauritania. Individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency may develop acute hemolytic anemia when exposed to 8-aminoquinoline antimalarial drugs, which are indispensable for a complete cur
Externí odkaz:
https://doaj.org/article/d6efc26fa15c43aa8a8c96bdaa1f1a6a
Autor:
Oum Kelthoum Mamadou Djigo, Mohamed Abdallahi Bollahi, Moina Hasni Ebou, Mohamed Salem Ould Ahmedou Salem, Rachida Tahar, Hervé Bogreau, Leonardo Basco, Ali Ould Mohamed Salem Boukhary
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0220977 (2019)
BackgroundPrimaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency
Externí odkaz:
https://doaj.org/article/a4a1c735ffb942bca8d06f32a61df820
Autor:
Oum Kelthoum Mamadou, Djigo, Nicolas, Gomez, Mohamed Salem, Ould Ahmedou Salem, Leonardo, Basco, Ali, Ould Mohamed Salem Boukhary, Sébastien, Briolant
Publikováno v:
American Journal of Tropical Medicine and Hygiene
American Journal of Tropical Medicine and Hygiene, 2023, 108 (2), pp.449-455. ⟨10.4269/ajtmh.21-1081⟩
American Journal of Tropical Medicine and Hygiene, 2023, 108 (2), pp.449-455. ⟨10.4269/ajtmh.21-1081⟩
8-Aminoquinoline antimalarial drugs (primaquine, tafenoquine) are required for complete cure of Plasmodium vivax malaria, but they are contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. In the absence of spectrophot
Autor:
Mohamed Aly Ould Lemrabott, Khadijetou Mint Lekweiry, Jemila Deida, Oum Kelthoum Mamadou Djigo, Mohamed Salem Ould Ahmedou Salem, Yacoub Ould Khalef, Hervé Bogreau, Frédéric Simard, Leonardo Basco, Ali Ould Mohamed Salem Boukhary
Publikováno v:
Parasitologia; Volume 1; Issue 4; Pages: 257-268
The construction of dams along the Senegal River resulted in an increase in irrigated land areas and changes in the epidemiology and transmission of water-related diseases. The objective of this study was to update epidemiological data on malaria in
Autor:
Ali Ould Mohamed Salem Boukhary, Leonardo K. Basco, Nicolas Gomez, Yacoub Ould Khalef, Sébastien Briolant, Mohamed Salem Ould Ahmedou Salem, Oum Kelthoum Mamadou Djigo
Publikováno v:
Infectious Diseases of Poverty
Infectious Diseases of Poverty, BMC, 2021, 10 (1), ⟨10.1186/s40249-021-00889-2⟩
Infectious Diseases of Poverty, 2021, 10 (1), ⟨10.1186/s40249-021-00889-2⟩
Infectious Diseases of Poverty, Vol 10, Iss 1, Pp 1-13 (2021)
Infectious Diseases of Poverty, BMC, 2021, 10 (1), ⟨10.1186/s40249-021-00889-2⟩
Infectious Diseases of Poverty, 2021, 10 (1), ⟨10.1186/s40249-021-00889-2⟩
Infectious Diseases of Poverty, Vol 10, Iss 1, Pp 1-13 (2021)
Background The elimination of Plasmodium vivax malaria requires 8-aminoquinolines, which are contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to the risk of acute haemolytic anaemia. Several point-of-care devic
Autor:
Leonardo K. Basco, Mohamed Salem Ould Ahmedou Salem, Mohamed Abdallahi Bollahi, Boushab Mohamed Boushab, Oum Kelthoum Mamadou Djigo, Nasserdine Papa Mze, Aymeric Garre, Sileye Mamadou Diallo, Sébastien Briolant, Ali Ould Mohamed Salem Boukhary
Publikováno v:
Pathogens
Pathogens, 2021, 10 (8), pp.931. ⟨10.3390/pathogens10080931⟩
Pathogens, MDPI, 2021, 10 (8), pp.931. ⟨10.3390/pathogens10080931⟩
Pathogens, Vol 10, Iss 931, p 931 (2021)
Volume 10
Issue 8
Pathogens, 2021, 10 (8), pp.931. ⟨10.3390/pathogens10080931⟩
Pathogens, MDPI, 2021, 10 (8), pp.931. ⟨10.3390/pathogens10080931⟩
Pathogens, Vol 10, Iss 931, p 931 (2021)
Volume 10
Issue 8
Plasmodium vivax malaria is endemic in Mauritania. Individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency may develop acute hemolytic anemia when exposed to 8-aminoquinoline antimalarial drugs, which are indispensable for a complete cur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22270a15ea0c3f46f720ff2c3b0dd226
https://hal-amu.archives-ouvertes.fr/hal-03429269
https://hal-amu.archives-ouvertes.fr/hal-03429269
Autor:
Hervé Bogreau, Moina Hasni Ebou, Rachida Tahar, Leonardo K. Basco, Mohamed Salem Ould Ahmedou Salem, Mohamed Abdallahi Bollahi, Oum Kelthoum Mamadou Djigo, Ali Ould Mohamed Salem Boukhary
Publikováno v:
PLoS ONE
PLoS ONE, 2019, 14 (9), pp.e0220977. ⟨10.1371/journal.pone.0220977⟩
PLoS ONE, Public Library of Science, 2019, 14 (9), pp.e0220977. ⟨10.1371/journal.pone.0220977⟩
PLoS ONE, Vol 14, Iss 9, p e0220977 (2019)
PLoS ONE, 2019, 14 (9), pp.e0220977. ⟨10.1371/journal.pone.0220977⟩
PLoS ONE, Public Library of Science, 2019, 14 (9), pp.e0220977. ⟨10.1371/journal.pone.0220977⟩
PLoS ONE, Vol 14, Iss 9, p e0220977 (2019)
BackgroundPrimaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency